Navigation Links
Discharge of First U.S. DuraHeart(TM) Patient
Date:8/21/2008

ANN ARBOR, Mich., Aug. 21 /PRNewswire/ Terumo Heart, Inc. today announced the discharge of the first U.S. patient implanted with the DuraHeart(TM) Left Ventricular Assist System (LVAS). The patient was discharged home on August 14th, from the University of Michigan Health System, 15 days after receiving the device.

The patient is a 62-year-old man from Livonia, Michigan, who has been suffering from heart failure for nearly 20 years. He is the first U.S. patient to receive a ventricular assist system that utilizes advanced magnetic levitation (Mag-Lev), a new, innovative type of technology.

Dr Pagani, National Co-Principal Investigator for the U.S. pivotal trial of the DuraHeart LVAS commented on the recent discharge. "We are extremely pleased with the performance of the DuraHeart and the recovery of our patient to an excellent functional state to permit discharge. We look forward to expanding upon our early experience with the DuraHeart in the near future."

The goal of these devices is to return the patient back to a relatively normal lifestyle and to provide improved "quality of life." "We are delighted that the FDA has allowed us to begin this trial with no restriction on patient discharge, which has not been true of some of the other devices currently conducting Trials in the United States," said Chisato Nojiri, M.D., PhD, Chief Executive Officer for Terumo Heart, Inc.

Earlier generation Left Ventricular Assist devices are prone to hemolysis, blood clots and mechanical failure. Significant advances have been made in the DuraHeart LVAS to potentially overcome these problems. Dr. Nojiri explained: "We have a unique pump design that combines advanced "Mag-Lev" technology and a centrifugal pump. The "Mag-Lev" allows for the complete elimination of mechanical contact within the blood flow path, minimizing the chance of mechanical failure. This is expected to significantly improve the clinical performance and long-term potential of th
'/>"/>

SOURCE Terumo Heart, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. First FLEXUS(TM) Interspinous Spacer Surgeries for IDE Clinical Trial
2. Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma
3. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
4. Alexion Secures U.S. Patent for ALXN6000, a First-In-Class Anti-CD200 Monoclonal Antibody
5. First DuraHeart(TM) Left Ventricular Assist System Implanted in the U.S. Pivotal Trial
6. First U.S. Patient to Receive New Heart-Assist Device Doing Well After Surgery at University of Michigan
7. MicroDose Technologies Announces Achievement of Phase I Clinical Milestone Triggering First Milestone Payment Under Collaboration with Merck & Co., Inc.
8. First Molecular Tem-PCR Test to Identify Multiple Forms of Staph and MRSA Obtains CLIA Certificate
9. Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US
10. First Ever Study on Alzheimers Disease Treatment in Hispanics Presented at Major Medical Meeting
11. Seattles Swedish Cancer Institute First in U.S. to Treat Cancer Patient with Elekta VMAT

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... Reportlinker.com announces that a...talogue: ,, HPLC Systems & Accessories - A...er.com/p0164366/HPLC-Systems--Accessories---A-Worl... Chromatography has emerged as a workhorse technol...verage, research and development, and industrial c...
(Date:12/1/2009)...J., Dec. 1 Merck & Co., Inc. t...tration (FDA) has approved ZEGERID OTC(TM) (omepra...or over-the-counter treatment of frequent heartbur...by Schering-Plough HealthCare Products, Inc., the ...nc. Schering-Plough and Merck merged on November 3...
(Date:12/1/2009)... Reportlinker.com announces that a...talogue: ,, Direct to Consumer (DTC) Advertisi...Outlook, Regulatory Landscape and Case Studies ,...o-Consumer-DTC-Advertising-in-Pharmaceuticals---Cu...pe-and-Case-Studies.html ,, Summary ,, Th...
Breaking Medicine Technology:Reportlinker Adds HPLC Systems & Accessories - A World Market Review 2Reportlinker Adds HPLC Systems & Accessories - A World Market Review 3Reportlinker Adds HPLC Systems & Accessories - A World Market Review 4Reportlinker Adds HPLC Systems & Accessories - A World Market Review 5Reportlinker Adds HPLC Systems & Accessories - A World Market Review 6Reportlinker Adds HPLC Systems & Accessories - A World Market Review 7FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 2FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 3FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 4Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 2Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 3Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 4Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 5Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 6Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 7Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 8New Appointments at London Genetics to Drive Strategy Forward 14144 1New Appointments at London Genetics to Drive Strategy Forward 14144 2New Appointments at London Genetics to Drive Strategy Forward 14144 3New Appointments at London Genetics to Drive Strategy Forward 14144 4Henry Ford Hospital Offers Free Prostate Cancer Screenings 57643 1AMDL Inc Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Alternext US 14143 1AMDL Inc Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Alternext US 14143 2AMDL Inc Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Alternext US 14143 3AMDL Inc Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Alternext US 14143 4AMDL Inc Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Alternext US 14143 5
...,Bulletin Board: GOVX), an Atlanta based biotechno... immunogenicity data from its full-dose HIV/AIDS,v... This full-dose trial is the second in a series of...fety and immunogenicity of the GeoVax,HIV/AIDS vac...ved vaccine,and 6 received placebo, this trial pro...
...nce,Applications International Corporation (NYSE: ...act extension by the National Institute of Allergy...obiology and Infectious,Diseases (DMID), part of t...ia vaccine production and support services. The s...mated value of,$32.7 million. The contract extensi...
Other Medicine Technology:Excellent Results Received from GeoVax's Full-Dose HIV/AIDS Vaccine Trial 2Excellent Results Received from GeoVax's Full-Dose HIV/AIDS Vaccine Trial 3Excellent Results Received from GeoVax's Full-Dose HIV/AIDS Vaccine Trial 4SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases 2
(Date:12/2/2009)...ilies around the world will join together for the ...ng Sunday, December 13 to remember all children wh...ll be held in the United States and around the glo...ss candle lighting. , Oak...sands of families around the world, grieving the l...
(Date:12/2/2009)...the New Year traditionally inspires making resolut...care. What to do to ensure the energy, and positiv...010? It’s easy; make self-care the #1 prior...y mission. It isn,t any wonder their products exce...ide to safe cosmetic products. , ...
(Date:12/2/2009)...l Products Inc., an industry leader in healthcare ...s the opening of its new headquarters in the Irvin...search Drive, Irvine, California 92618. In additio... Irvine Spectrum plus an assembly and distribution...expansion reflects Links Medical,s rapid growth an...
(Date:12/2/2009)...com Enables Personal Health Record Devices with Me...gton, PA (PRWEB) December 2, 2009 -- Perhaps the b...eir own medical records. With the advent of Person... medical records is easier than ever. MyEMRChoice....logy company has added services that will populate...
(Date:12/2/2009)...s Achieves IBM Ready for LINUX designation and enh...he mainframe and contemporary systems running Linu...December 2, 2009 -- eCube Systems, a leader in leg... announced that it has achieved the IBM Ready for ...middleware. This mark certifies NXTera has met co...
Breaking Medicine News(10 mins):Health News:Bereaved Families Unite for Compassionate Friends Worldwide Candle Lighting 2Health News:The New Year's Resolution that Fuels Them All: Self-Care; Garden of Eve Makes Self-Care Through Safe Skin Care # 1 Priority 2Health News:The New Year's Resolution that Fuels Them All: Self-Care; Garden of Eve Makes Self-Care Through Safe Skin Care # 1 Priority 3Health News:The New Year's Resolution that Fuels Them All: Self-Care; Garden of Eve Makes Self-Care Through Safe Skin Care # 1 Priority 4Health News:Links Medical Opens New Headquarters, Prepares to Launch Medical-Grade Manuka Honey 2Health News:Links Medical Opens New Headquarters, Prepares to Launch Medical-Grade Manuka Honey 3Health News:Personal Health Records On-Demand, In Your Pocket 2Health News:eCube Delivers Linux on System z Support for NXTera High Performance Middleware 2Health News:eCube Delivers Linux on System z Support for NXTera High Performance Middleware 3
...ILLE, Tenn., Feb. 22 HCA Inc. announced today the...debt tender offer to,purchase up to $500 million o... ("Notes"). The tender offer is being made on the ... identifies the Notes that are the subject of the ...
..., Joe and Nick Jonas Kick-Off Campaign with Launch...n the New Breakfast BREAKS TV Commercial,Jonas Bro...ool with Concert to Announce New Breakf..., the,Jonas Brothers, for a national campaign to r...
...it Cogon at HIMSS - Bo...FL-based Cogon,Systems, Inc. is excited to announc...rnet-based health information exchange platform, t...a. In the coming year,Cogon Systems, Inc. has been...
...is conference will use a cross-disciplinary approa...ural products and their prospects for continued co...view of recent developments impacting the discover...operation, bioinformatics, etc., will be discussed...
...orto-duodenal fistulae (ADF) are the most frequent...t presenting sign of ADF is upper gastrointestinal...nderwent an aortic-bi-femoral bypass five years ag...can showed in the third duodenal segment the prese...
...flammatory bowel disease (IBD) is a chronic recurr...latively higher morbidity in young adults, in whom...re adversely influenced. A number of guidelines fo...he actual quality of care for patients with IBD in...
Other Medicine News:Health News:HCA Announces Preliminary Results for Its Debt Tender Offer 2Health News:HCA Announces Preliminary Results for Its Debt Tender Offer 3Health News:HCA Announces Preliminary Results for Its Debt Tender Offer 4Health News:Breakfast BREAKS and Teen Music Phenomenon the Jonas Brothers Team Up to Raise Awareness about the Importance of Eating Breakfast 2Health News:Breakfast BREAKS and Teen Music Phenomenon the Jonas Brothers Team Up to Raise Awareness about the Importance of Eating Breakfast 3Health News:Breakfast BREAKS and Teen Music Phenomenon the Jonas Brothers Team Up to Raise Awareness about the Importance of Eating Breakfast 4Health News:Cogon Systems, Inc. Supports the Formation of Virtual Health Communities with its Community MOMENT OF CARE(R) 2Health News:A strange case of upper obstructive syndrome 2Health News:Do patients with inflammatory bowel disease receive optimal care? 2
MULTI-LINK OTW PENTA Coronary Stent System
NIR Elite OTW Stent System
MULTI-LINK OTW PIXEL Coronary Stent System
FemoStopplus Femoral Compression System
Medicine Products: